Citadel Advisors’s Cumberland Pharmaceuticals CPIX Stock Holding History
Bought
Maintained
Sold
Other funds holding CPIX
Citadel Advisors's CPIX Position: Q3 2026 in Review
Citadel Advisors reduced its Cumberland Pharmaceuticals (CPIX) stake by 14% in Q3 2026, selling an estimated $76.7K and leaving 62,817 shares worth $492K. The position accounts for ﹤0.01% of the portfolio, ranked #10240.
Citadel Advisors first reported a position in CPIX in Q2 2013 and has held it in 20 quarters since. 35 funds tracked by Wall St. Rank hold CPIX as of Q3 2026.
- Citadel Advisors held 62,817 shares of Cumberland Pharmaceuticals worth $492K as of Q3 2026.
- Citadel Advisors sold 10,574 Cumberland Pharmaceuticals shares in Q3 2026, an estimated $76.7K.
- Cumberland Pharmaceuticals made up ﹤0.01% of Citadel Advisors's portfolio in Q3 2026, its #10240 holding.
- Citadel Advisors first reported a position in Cumberland Pharmaceuticals in Q2 2013 and has held it in 20 quarters since.
- 35 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q3 2026.
Based on Citadel Advisors's 13F filing for Q3 2026, filed 16 Nov 2026.